TMPYP4 exerted antitumor effects in human cervical cancer cells through activation of p38 mitogen-activated protein kinase
Abstract Background The aim of the present study was to investigate the potential effects of the 5,10,15,20‑tetrakis (1‑meth‑ ylpyridinium‑4‑yl) porphyrin (TMPyP4) on the proliferation and apoptosis of human cervical cancer cells and the underlying...
Guardado en:
Autores principales: | Cheng,Ming‑Jun, Cao,Yun‑Gui |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2017
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602017000100217 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Protective effect of Anwulignan against D-galactose-induced hepatic injury through activating p38 MAPK–Nrf2–HO-1 pathway in mice
por: Gao J, et al.
Publicado: (2018) -
Revealing the suppressive role of protein kinase C delta and p38 mitogen-activated protein kinase (MAPK)/NF-κB axis associates with lenvatinib-inhibited progression in hepatocellular carcinoma in vitro and in vivo
por: Ching-Hsuan Wu, et al.
Publicado: (2022) -
Escin induces apoptosis in ovarian cancer cell line by triggering S-phase cell cycle arrest and p38 MAPK/ERK pathway inhibition
por: Wei Zhao, et al.
Publicado: (2022) -
LncRNA KCNQ1OT1 (potassium voltage-gated channel subfamily Q member 1 opposite strand/antisense transcript 1) aggravates acute kidney injury by activating p38/NF-κB pathway via miR-212-3p/MAPK1 (mitogen-activated protein kinase 1) axis in sepsis
por: Haixia Wang, et al.
Publicado: (2021) -
Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes
por: Mikkel G. Terp, et al.
Publicado: (2021)